HighTower Advisors, LLC

Position in RLAY — Relay Therapeutics, Inc.

CIK 1462245 CHICAGO, IL

Position in RLAY

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$195,164

+$88,321 QoQ

Shares Held

10,431

-2.9% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#190

of 256 holders

Holding Since

Jun 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HighTower Advisors, LLC holds $312,855,129 across 115 Biotechnology names. RLAY ranks #67 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INBX	Inhibrx Biosciences, Inc.	870,551	$82,484,707
2	REGN	Regeneron Pharmaceuticals, Inc.	64,650	$40,311,861
3	ALNY	Alnylam Pharmaceuticals, Inc.	105,045	$31,621,696
4	VRTX	Vertex Pharmaceuticals Inc / Ma	49,020	$24,349,704
5	RPRX	Royalty Pharma plc	285,630	$16,015,274
6	EXEL	Exelixis, Inc.	291,162	$15,842,124
7	AXSM	Axsome Therapeutics, Inc.	56,313	$13,783,733
8	ARWR	Arrowhead Pharmaceuticals, Inc.	140,394	$11,443,514

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$195,164	10,431	-2.9%	Shares	Sole	2026-08-05
2026-03-31	$106,843	10,738	+4.1%	Shares	Sole	2026-05-05
2025-06-30	$35,707	10,320	-95.8%	Shares	Sole	2025-08-11
2025-03-31	$647,601	247,176	+23.7%	Shares	Sole	2025-05-13
2024-12-31	$822,941	199,743	+28.9%	Shares	Sole	2025-02-07
2024-09-30	$1,096,833	154,920	-48.9%	Shares	Sole	2024-11-14
2024-06-30	$1,977,809	303,345	+22.7%	Shares	Sole	2024-08-13
2024-03-31	$2,052,515	247,291	+16.2%	Shares	Sole	2024-05-06
2023-12-31	$2,342,828	212,791	-25.4%	Shares	Sole	2024-02-12
2023-09-30	$2,399,734	285,343	+1490.5%	Shares	Sole	2023-11-08
2022-06-30	$300,511	17,941	—	Shares	Sole	2022-08-10
No filing history on record for this holder in this stock.